Managing the unavoidable: A practical approach to handling TUPs
Technically unavoidable particles (TUPs) are found in chemical raw materials, such as excipients. They do not pose a risk to patient safety, but can create problems if not managed well. Merck KGaA's Dr Torsten Schadendorf and Jennifer Standare explain
Breaking News
Civica and Thermo Fisher join forces to manufacture drugs in short supply
Thermo Fisher has agreed to produce Civica-owned Abbreviated New Drug Applications to secure the manufacture of certain ...
Evonik acquires US phytochemical supplier
The acquisition of Wilshire Technologies has added a sustainable portfolio of phytochemicals and derivatives for the ...
US gene therapy CDMO enters virus manufacturing partnership
Vigene Biosciences will provide manufacturing services for ASC for both early-stage and commercial virus production
Triton X-100 surfactant joins the list of contaminants of emerging concern
Evidence-based concerns about the environmental consequences of the widespread use of Triton X-100 have prompted calls ...
European collaboration begins development of antibody-based senolytics
Velabs Therapeutics has agreed to work with alytas therapeutics again to develop antibody-based senolytics
WuXi STA opens oligonucleotide large-scale manufacturing facility
API production at the Changzhou site can manufacture oligonucleotide ingredients up to 1 mol/synthesis run
IntelGenX: Oral films are drug development’s patent trick
Exploiting improvements in bioavailability, the Canadian company has developed unique oral film technology to help ...
Creative Peptides launches synthetic peptide APIs in the US
New York-based Creative Peptides has a portfolio of more than 100 peptides and related products available from grams to ...
Colorcon completes multimillion dollar manufacturing expansion
Global excipient supplier has invested in the consolidation of multiple US legacy buildings into one unified ...
Developing and manufacturing accurate and reproducible APIs
The measurement of the refractive index (RI) is employed by a wide variety of industries to determine the level of ...
Medical cannabis made in Italy
Dr Fabio Di Francesco, a compounding pharmacist based in Rome, describes how cannabis is used in various dosage forms ...
The rise of HPAPIs: Putting safety first
The increasing focus on highly potent active pharmaceutical ingredients (HPAPIs) in pharmaceutical development ...
Azelis to enter Latin America with the acquisition of Megafarma
The transaction is expected to be completed within the next month
Swedish biotech chooses Recipharm for sepsis drug manufacturing
Recipharm has signed a deal with Aptahem to develop an injectable formulation for an upcoming Phase 1 study
In Brief
Most Popular in Ingredients
Featured Companies
Reports
